Side-by-side financials for ALDX and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALDX | NVS |
|---|---|---|
| Market cap | - | $292.08 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | -$33.85M | - |
| SEC filings | 630 | 947 |
Full pages: Aldeyra Therapeutics, Inc. and Novartis AG, or browse the full rankings.